Quality of Care and Outcomes of Inpatients with COPD: A Multi-Center Study in China

Fengyan Wang,1,* Mingdie Wang,1,* Xiaoyan Chen,2,* Aiqi Song,3,* Hui Zeng,3 Jiawei Chen,3 Lingwei Wang,4 Wanyi Jiang,1 Mei Jiang,1 Weijuan Shi,1 Yuqi Li,1 Heng Zhong,5 Rongchang Chen,1,4,* Zhenyu Liang1,* 1State Key Laboratory o...

Full description

Saved in:
Bibliographic Details
Main Authors: Wang F, Wang M, Chen X, Song A, Zeng H, Chen J, Wang L, Jiang W, Jiang M, Shi W, Li Y, Zhong H, Chen R, Liang Z
Format: Article
Language:English
Published: Dove Medical Press 2025-05-01
Series:International Journal of COPD
Subjects:
Online Access:https://www.dovepress.com/quality-of-care-and-outcomes-of-inpatients-with-copd-a-multi-center-st-peer-reviewed-fulltext-article-COPD
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849418025478914048
author Wang F
Wang M
Chen X
Song A
Zeng H
Chen J
Wang L
Jiang W
Jiang M
Shi W
Li Y
Zhong H
Chen R
Liang Z
author_facet Wang F
Wang M
Chen X
Song A
Zeng H
Chen J
Wang L
Jiang W
Jiang M
Shi W
Li Y
Zhong H
Chen R
Liang Z
author_sort Wang F
collection DOAJ
description Fengyan Wang,1,* Mingdie Wang,1,* Xiaoyan Chen,2,* Aiqi Song,3,* Hui Zeng,3 Jiawei Chen,3 Lingwei Wang,4 Wanyi Jiang,1 Mei Jiang,1 Weijuan Shi,1 Yuqi Li,1 Heng Zhong,5 Rongchang Chen,1,4,* Zhenyu Liang1,* 1State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510120, People’s Republic of China; 2Foshan Fourth People’s Hospital, Foshan, 528000, People’s Republic of China; 3Guangzhou Medical University, Guangzhou, 510182, People’s Republic of China; 4Hetao Institute of Guangzhou National Laboratory, Shenzhen, 518000, People’s Republic of China; 5R&D China, AstraZeneca, Shanghai, 200040, People’s Republic of China*These authors contributed equally to this workCorrespondence: Zhenyu Liang, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510120, People’s Republic of China, Tel +86 13560157649, Email 490458234@qq.com Rongchang Chen, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510120, People’s Republic of China, Tel +86 13902273260, Email chenrc@vip.163.comObjective: Hospitalization due to chronic obstructive pulmonary disease (COPD) exacerbation is linked to worse prognosis and increased healthcare burden, especially in low- and middle-income countries. This study aimed to evaluate the quality of care and outcomes among inpatients with COPD and to identify prognostic factors relate to healthcare quality indicators.Methods: A multi-center, retrospective longitudinal study was conducted. Patients hospitalized for COPD exacerbations between January and December 2017 were randomly sampled from 16 secondary or tertiary public general hospitals in China. Healthcare quality process indicators and clinical outcomes were collected from medical records and patient questionnaires. The median follow-up period was 666 days. Multivariate logistic regression analysis was used to identify risk factors for readmission or death within 30 days after discharge and for one-year mortality.Results: A total of 891 inpatients with COPD were included. Among them, 14.3% underwent post-bronchodilator spirometry. Documentation of exacerbation history and symptom scores was found in 16.8% and 1.2% of medical records, respectively. Long-acting bronchodilators (LABDs) were prescribed at discharge in 30.3% of cases. Verbal counseling was the primary approach to smoking cessation education, rather than the 5A method. The 30-day readmission rate was 7.1%. The average exacerbation rate was 0.94 per patient during the following year, and the one-year mortality rate was 7.2%. Prescription of inhaled LABDs at discharge was significantly associated with a lower risk of readmission or death within 30 days (HR 0.51, 95% CI 0.29– 0.90, p=0.020). The presence of cardiovascular disease was associated with an increased risk of death within one year (HR 2.34, 95% CI 1.24– 4.41, p=0.002).Conclusion: The quality of inpatient care for COPD in China showed deficiencies in diagnostics, disease assessment, and patient education. Prescription of inhaled LABDs at discharge was a key quality measure that significantly reduced short-term readmission or mortality, highlighting its importance. Standardized protocols and clinician training are essential to improve patient outcomes.Keywords: chronic obstructive pulmonary disease, quality in health care, long-acting bronchodilators, patient readmission, prognosis
format Article
id doaj-art-e679ffe007ff44bda52430e25cf10c68
institution Kabale University
issn 1178-2005
language English
publishDate 2025-05-01
publisher Dove Medical Press
record_format Article
series International Journal of COPD
spelling doaj-art-e679ffe007ff44bda52430e25cf10c682025-08-20T03:32:33ZengDove Medical PressInternational Journal of COPD1178-20052025-05-01Volume 20Issue 117871795103465Quality of Care and Outcomes of Inpatients with COPD: A Multi-Center Study in ChinaWang F0Wang MChen XSong A1Zeng HChen JWang L2Jiang WJiang MShi W3Li YZhong HChen RLiang Z4State Key Laboratory of Respiratory DiseaseGuangzhou Medical University, Guangzhou 510182, ChinaKey Laboratory of Shenzhen Respiratory DiseasesGuangzhou Institute of Respiratory HealthDepartment of Respiratory and Critical Care MedicineFengyan Wang,1,* Mingdie Wang,1,* Xiaoyan Chen,2,* Aiqi Song,3,* Hui Zeng,3 Jiawei Chen,3 Lingwei Wang,4 Wanyi Jiang,1 Mei Jiang,1 Weijuan Shi,1 Yuqi Li,1 Heng Zhong,5 Rongchang Chen,1,4,* Zhenyu Liang1,* 1State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510120, People’s Republic of China; 2Foshan Fourth People’s Hospital, Foshan, 528000, People’s Republic of China; 3Guangzhou Medical University, Guangzhou, 510182, People’s Republic of China; 4Hetao Institute of Guangzhou National Laboratory, Shenzhen, 518000, People’s Republic of China; 5R&D China, AstraZeneca, Shanghai, 200040, People’s Republic of China*These authors contributed equally to this workCorrespondence: Zhenyu Liang, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510120, People’s Republic of China, Tel +86 13560157649, Email 490458234@qq.com Rongchang Chen, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510120, People’s Republic of China, Tel +86 13902273260, Email chenrc@vip.163.comObjective: Hospitalization due to chronic obstructive pulmonary disease (COPD) exacerbation is linked to worse prognosis and increased healthcare burden, especially in low- and middle-income countries. This study aimed to evaluate the quality of care and outcomes among inpatients with COPD and to identify prognostic factors relate to healthcare quality indicators.Methods: A multi-center, retrospective longitudinal study was conducted. Patients hospitalized for COPD exacerbations between January and December 2017 were randomly sampled from 16 secondary or tertiary public general hospitals in China. Healthcare quality process indicators and clinical outcomes were collected from medical records and patient questionnaires. The median follow-up period was 666 days. Multivariate logistic regression analysis was used to identify risk factors for readmission or death within 30 days after discharge and for one-year mortality.Results: A total of 891 inpatients with COPD were included. Among them, 14.3% underwent post-bronchodilator spirometry. Documentation of exacerbation history and symptom scores was found in 16.8% and 1.2% of medical records, respectively. Long-acting bronchodilators (LABDs) were prescribed at discharge in 30.3% of cases. Verbal counseling was the primary approach to smoking cessation education, rather than the 5A method. The 30-day readmission rate was 7.1%. The average exacerbation rate was 0.94 per patient during the following year, and the one-year mortality rate was 7.2%. Prescription of inhaled LABDs at discharge was significantly associated with a lower risk of readmission or death within 30 days (HR 0.51, 95% CI 0.29– 0.90, p=0.020). The presence of cardiovascular disease was associated with an increased risk of death within one year (HR 2.34, 95% CI 1.24– 4.41, p=0.002).Conclusion: The quality of inpatient care for COPD in China showed deficiencies in diagnostics, disease assessment, and patient education. Prescription of inhaled LABDs at discharge was a key quality measure that significantly reduced short-term readmission or mortality, highlighting its importance. Standardized protocols and clinician training are essential to improve patient outcomes.Keywords: chronic obstructive pulmonary disease, quality in health care, long-acting bronchodilators, patient readmission, prognosishttps://www.dovepress.com/quality-of-care-and-outcomes-of-inpatients-with-copd-a-multi-center-st-peer-reviewed-fulltext-article-COPDChronic Obstructive Pulmonary DiseaseQuality in Health CareLong-acting BronchodilatorsPatient ReadmissionPrognosis
spellingShingle Wang F
Wang M
Chen X
Song A
Zeng H
Chen J
Wang L
Jiang W
Jiang M
Shi W
Li Y
Zhong H
Chen R
Liang Z
Quality of Care and Outcomes of Inpatients with COPD: A Multi-Center Study in China
International Journal of COPD
Chronic Obstructive Pulmonary Disease
Quality in Health Care
Long-acting Bronchodilators
Patient Readmission
Prognosis
title Quality of Care and Outcomes of Inpatients with COPD: A Multi-Center Study in China
title_full Quality of Care and Outcomes of Inpatients with COPD: A Multi-Center Study in China
title_fullStr Quality of Care and Outcomes of Inpatients with COPD: A Multi-Center Study in China
title_full_unstemmed Quality of Care and Outcomes of Inpatients with COPD: A Multi-Center Study in China
title_short Quality of Care and Outcomes of Inpatients with COPD: A Multi-Center Study in China
title_sort quality of care and outcomes of inpatients with copd a multi center study in china
topic Chronic Obstructive Pulmonary Disease
Quality in Health Care
Long-acting Bronchodilators
Patient Readmission
Prognosis
url https://www.dovepress.com/quality-of-care-and-outcomes-of-inpatients-with-copd-a-multi-center-st-peer-reviewed-fulltext-article-COPD
work_keys_str_mv AT wangf qualityofcareandoutcomesofinpatientswithcopdamulticenterstudyinchina
AT wangm qualityofcareandoutcomesofinpatientswithcopdamulticenterstudyinchina
AT chenx qualityofcareandoutcomesofinpatientswithcopdamulticenterstudyinchina
AT songa qualityofcareandoutcomesofinpatientswithcopdamulticenterstudyinchina
AT zengh qualityofcareandoutcomesofinpatientswithcopdamulticenterstudyinchina
AT chenj qualityofcareandoutcomesofinpatientswithcopdamulticenterstudyinchina
AT wangl qualityofcareandoutcomesofinpatientswithcopdamulticenterstudyinchina
AT jiangw qualityofcareandoutcomesofinpatientswithcopdamulticenterstudyinchina
AT jiangm qualityofcareandoutcomesofinpatientswithcopdamulticenterstudyinchina
AT shiw qualityofcareandoutcomesofinpatientswithcopdamulticenterstudyinchina
AT liy qualityofcareandoutcomesofinpatientswithcopdamulticenterstudyinchina
AT zhongh qualityofcareandoutcomesofinpatientswithcopdamulticenterstudyinchina
AT chenr qualityofcareandoutcomesofinpatientswithcopdamulticenterstudyinchina
AT liangz qualityofcareandoutcomesofinpatientswithcopdamulticenterstudyinchina